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brachytherapy of the prostate, compared to a SSCP. The primary 
objective of this study was to investigate whether a DSCP leads to 
more similarity between an online plan based on TRUS and a post plan 
based on CT, compared with SSCP. The secondary objective was to 
determine whether the post-plan based DVH parameters improved 
using with the DSCP technique compared with the SSCP technique. 
Materials and Methods: In the study 50 consecutive patients with 
prostate cancer were included, who were treated between March 
2008 and March 2010. The first 25 of these patients had their online 
planning based on a SSCP, the plans of the other 25 patients were 
based on a DSCP TRUS. Three weeks after implantation a post 
planning was made based on CT. TRUS online and CT post plan dose 
volume histogram (DVH) parameters, D90 and V100, were compared 
for both groups. Also, the post plan DVH parameters of SSCP were 
compared with DSCP. The possible factors that might influence the 
post plan D90 and V100 were analysed using ANOVA. 
Results:  
 The SSCP and DSCP online mean D90 and V100 were significantly 
larger than post plan mean D90 and V100 (P < 0.01). The post plan 
mean D90 and mean V100 were both non-significantly larger for the 
with SSCP implanted patients, compared to the with DSCP implanted 
patients (P = 0.76 and P = 0.68).  The online-plan D90 and V100 in the 
DSCP group were very similar among the patients, compared to the 
SSCP group. The SD's of the D90 of SSCP and DSCP were 14.2 Gy and 
11.1 Gy and the V100 ranged from 91.5 to 99.1% and from 97.7 to 
99.9%, respectively. ANOVA showed significant impact of prostate 
volume on the post-plan D90 (P<0.01) and V100 (P = 0.02). 
Conclusions: The longer sagittal view of the prostate and surrounding 
tissues with the DSCP enabled better visualisation in one view, which 
resulted in more homogeneous online plans among patients. However, 
the DVH parameters showed that this did not lead to more accurate 
online planning. The TRUS and CT based D90 and V100 showed 
statistical significant difference, whereas the post plan based D90 and 
V100 did not improve with the DSCP technique compared to the SSCP 
technique. Both types of probes are equally accurate for permanent 
prostate brachytherapy treatment planning. The most important 
factor found to influence DVH parameters was the prostate volume. 
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Purpose/Objective: In 3-Tesla MRI image, the seeds and the contours 
of prostate and urethra are clearer than in 1.5-Tesla MRI image. 
Meanwhile, their reliability has been less investigated, and it remains 
unclear which procedure is more reliable. We assessed the 
interobserver variability in 3-Tesla and 1.5-Tesla MRI/CT fusion-based 
postimplant dosimetry of prostate brachytherapy. 
Materials and Methods: Between July 2009 and December 2010, a 
total of 26 consecutive prostate cancer patients underwent 
brachytherapy and 1.5-Tesla MRI and CT (1.5T) were performed on 
day 30. Subsequently, between December 2010 and November 2011, 
another  26 consecutive prostate cancer patients underwent 
brachytherapy and  3-Tesla MRI and CT (3T) were performed on day 
30. All the patients were treated with 144 Gy of brachytherapy alone. 
Two radiation oncologists performed MRI/CT fusion-based postimplant 
dosimetry. The interobserver variability of dose-volume histogram 
(DVH) parameters (prostate D90, prostate V100, prostate V150, 
urethral D5, and urethral V200) was calculated by using Pearson’s 
correlation coefficients. Differences in means of DVH parameters were 
also tested by using a paired t test. 
Results: Pearson’s correlation coefficients of 3T were larger than 
those of 1.5T in all the DVH parameters (prostate D90, 1.5T: 0.66, 3T: 
0.85; prostate V100, 1.5T: 0.63, 3T: 0.68; prostate V150, 1.5T: 0.96, 
3T: 0.98; urethral D5, 1.5T: 0.84, 3T: 0.92; urethral V200, 1.5T: 0.77, 
3T: 0.92). In a paired t test, none of the DVH parameters were 
statistically significant in 3T (0.082≤p≤0.26). In 1.5T, however, 
significant differences were observed in prostate D90, prostate V100, 
and prostate V150 (p<0.001). 
Conclusions: The interobserver variability of 3-Tesla MRI/CT fusion-
based postimplant dosimetry was smaller than that of 1.5-Tesla 
MRI/CT fusion-based postimplant dosimetry, suggesting that the 
former is more reliable among prostate cancer patients undergoing 
brachytherapy. 
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Purpose/Objective: The electromagnetic tracking systems 
(EMTS),initially employed in virtual reality experiments, are more and 
more integrated in several medical protocols. That technology can 
improve the accuracy of physician's gestures from real time tracking 
of positions and orientations of needles or catheters. However, the 
electromagnetic field distortion, due to metallic structures or medical 
devices in the environment, is not negligible and has to be 
characterized. For prostate brachytherapy, there are several metallic 
elements and electronic tools close to the zone of detection: the 
operating table, the needles, the template, the ultra-sound probe 
stabilizer and an important concentration of small seeds in volume of 
interest during low-dose rate (LDR) brachytherapy. The purpose of 
this study is to characterize the performance of the planar field 
generator Aurora (Northern Digital Inc., Waterloo, Canada) as a real-
time, high accuracy needle guidance technology in prostate 
brachytherapy.  
Materials and Methods: All measurements have been recorded in an 
environment free of electromagnetic disturbances. The 
characterization of the planar field generator Aurora from NDI 
included the definition of volume boundaries, the errors calculations 
of position and orientation for the sensor throughout this volume.For 
these measurements the sensor (5 degrees of freedom (5DOF)) was 
integrated into a needle from a biopsy introducer set (PHILIPS 
developed EM system). The needle support could be moved accurately 
with a sub-millimeters displacement (± 0.25mm) everywhere in the 
measurement volume (600 x 600 x 600 mm³) in front of the generator. 
To estimate the accuracy of position, 486 measurements were 
recorded into the volume of interest. In addition, 22 measurement 
points, covering from X to Y degrees, were utilized to evaluate the 
accuracy of orientation measurements. The latter were repeated for 
needle orientations parallel (± 90°)and perpendicular (0°) to the 
central axis of the field generator. 
Results: Results show that the standard deviation on sensor position is 
less than 0.04 mm when needle is located within 26 cm of 
generator,but start increases significantly beyond 35 cm. When needle 
is on volume edges(at 60 cm) the position defined by EMTS is 
underestimated by 16.0±0.6 mm. The errors on the measured 
orientation were low at ±1°, except when the needle is perpendicular 
to the generator, at more than 375 (±1) mm; the error on the 
orientation rises exponentially with distance up to 4.5° at 575 (±1) 
mm. 
Conclusions: Our work shows that the EMTS Aurora planar field 
generator seems to possess the needed accuracy to enable real-time 
needle/catheter guidance for brachytherapy applications. As 
recommended practices, the needle should be parallel with the 
generator plan, and the treatment zone should be ideally kept within 
  
 
 
  
 
